Search research articles
Contact Us
Filters
Showing results (101-110 of 257) with videos related to
Page
of 26
Sort By:
Molecular Cancer Therapeutics
|
July 22, 2017
Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes
Dandan Luo, Jumin Geng, Nasi Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 19, 2015
Porphyrin-phospholipid liposomes with tunable leakiness
Dandan Luo, Kevin A Carter, Aida Razi, et al.
Current Opinion in Biotechnology
|
January 21, 2021
Role of intravital imaging in nanomedicine-assisted anti-cancer therapy
Lisen Lu, Yajie Sun, Chao Wan, et al.
Bioconjugate Chemistry
|
June 10, 2015
Sulfonated Polyethylenimine for Photosensitizer Conjugation and Targeting
Upendra Chitgupi, Yumiao Zhang, Chi Y Lo, et al.
Biomacromolecules
|
July 23, 2011
Porphyrin-cross-linked hydrogel for fluorescence-guided monitoring and surgical resection
Jonathan F Lovell, Aron Roxin, Kenneth K Ng, et al.
Cell
|
December 9, 2008
Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax
Jonathan F Lovell, Lieven P Billen, Scott Bindner, et al.
Research Square
|
January 13, 2025
Fluence rate-dependent kinetics of light-triggered liposomal doxorubicin assessed by quantitative fluorescence-based endoscopic probe
Daniel J Rohrbach, Kevin A Carter, Dandan Luo, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Fluence rate-dependent kinetics of light-triggered liposomal doxorubicin assessed by quantitative fluorescence-based endoscopic probe
Daniel J Rohrbach, Kevin A Carter, Dandan Luo, et al.
International Journal of Molecular Sciences
|
February 13, 2025
Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe
Daniel J Rohrbach, Kevin A Carter, Dandan Luo, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 20, 2023
Orally-Delivered, Cytokine-Engineered Extracellular Vesicles for Targeted Treatment of Inflammatory Bowel Disease
Jingang Liu, He Ren, Chen Zhang, et al.
Page
of 26
Search research articles
Search
Showing results (101-110 of 257) with videos related to
Sort By:
Page
of 26
Molecular Cancer Therapeutics
|
July 22, 2017
Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes
Dandan Luo, Jumin Geng, Nasi Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 19, 2015
Porphyrin-phospholipid liposomes with tunable leakiness
Dandan Luo, Kevin A Carter, Aida Razi, et al.
Current Opinion in Biotechnology
|
January 21, 2021
Role of intravital imaging in nanomedicine-assisted anti-cancer therapy
Lisen Lu, Yajie Sun, Chao Wan, et al.
Bioconjugate Chemistry
|
June 10, 2015
Sulfonated Polyethylenimine for Photosensitizer Conjugation and Targeting
Upendra Chitgupi, Yumiao Zhang, Chi Y Lo, et al.
Biomacromolecules
|
July 23, 2011
Porphyrin-cross-linked hydrogel for fluorescence-guided monitoring and surgical resection
Jonathan F Lovell, Aron Roxin, Kenneth K Ng, et al.
Cell
|
December 9, 2008
Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax
Jonathan F Lovell, Lieven P Billen, Scott Bindner, et al.
Research Square
|
January 13, 2025
Fluence rate-dependent kinetics of light-triggered liposomal doxorubicin assessed by quantitative fluorescence-based endoscopic probe
Daniel J Rohrbach, Kevin A Carter, Dandan Luo, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Fluence rate-dependent kinetics of light-triggered liposomal doxorubicin assessed by quantitative fluorescence-based endoscopic probe
Daniel J Rohrbach, Kevin A Carter, Dandan Luo, et al.
International Journal of Molecular Sciences
|
February 13, 2025
Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe
Daniel J Rohrbach, Kevin A Carter, Dandan Luo, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 20, 2023
Orally-Delivered, Cytokine-Engineered Extracellular Vesicles for Targeted Treatment of Inflammatory Bowel Disease
Jingang Liu, He Ren, Chen Zhang, et al.
Page
of 26